絞り込み

16390

広告

「elotuzumab」の検索結果

153件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Treatment algorithms for multiple myeloma in Japan.

Combination therapy with monoclonal antibodies for treatment of newly diagnosed multiple myeloma.

CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.

Adoptive Cell Therapy in Multiple Myeloma.

The Clinical Pharmacology of Elotuzumab.

Immunotherapy in Multiple Myeloma.

How I treat: New agents in myeloma.

Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab.

Monoclonal Antibodies in Multiple Myeloma: A New Wave of the Future.

Meta-analysis of the efficacy of treatments for newly diagnosed and relapsed/refractory multiple myeloma with del(17p).

How I treat first relapse of myeloma.

Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth.

Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.

Elotuzumab as a Novel Anti-Myeloma Immunotherapy.

Current and developing synthetic pharmacotherapy for treating relapsed/refractory multiple myeloma.

New Agents in Multiple Myeloma: An Examination of Safety Profiles.

Hematologic Malignancies: Plasma Cell Disorders.

Recent progress in relapsed multiple myeloma therapy: implications for treatment decisions.

How is patient care for multiple myeloma advancing?

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
Sort by
※並べ替えは表示に時間がかかります